Nicolas Pauillac
Stock Analyst at Kepler Capital
(4.64)
# 836
Out of 4,421 analysts
377
Total ratings
55.4%
Success rate
15.8%
Average return
Main Sectors:
Stocks Rated by Nicolas Pauillac
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: GSK GSK plc | Upgraded: Buy | 1,500p → 2,516p | $1,923.00 | +30.84% | 2 | May 26, 2026 | |
| SWX: COPN Cosmo N.V. | Maintained: Buy | CHF 130.00 | $66.50 | +95.49% | 35 | May 11, 2026 | |
| SWX: SDZ Sandoz Group AG | Maintained: Buy | CHF 80.00 | $67.68 | +18.20% | 29 | May 11, 2026 | |
| EPA: CVX Carvolix SA | Maintained: Buy | €5.00 | $3.60 | +38.89% | 30 | May 4, 2026 | |
| EPA: OSE OSE Immunotherapeutics SA | Maintained: Buy | €8.20 | $3.58 | +128.79% | 40 | Apr 30, 2026 | |
| SWX: IDIA Idorsia Ltd | Maintained: Buy | CHF 4.50 | $5.85 | -23.01% | 1 | Apr 28, 2026 | |
| SWX: BION BB Biotech AG | Maintained: Buy | CHF 66.00 → CHF 73.00 | $44.20 | +65.16% | 15 | Apr 24, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €85.00 | $73.34 | +15.90% | 16 | Apr 23, 2026 | |
| ETR: FYB Formycon AG | Maintained: Buy | €33.00 | $19.60 | +68.37% | 51 | Apr 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 280.00 | $279.92 | +0.03% | 1 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €20.30 | $15.53 | +30.71% | 34 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €36.60 | $24.50 | +49.39% | 33 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €5.00 | $2.90 | +72.41% | 8 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €15.00 | $9.40 | +59.57% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €390.00 | $329.50 | +18.36% | 19 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | €0.80 → €0.64 | $0.0153 | n/a | 21 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $91 → $47 | $28.32 | n/a | 2 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €79.00 → €41.00 | $24.58 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $394 → $432 | $877.72 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €342.00 → €375.00 | $764.20 | n/a | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.60 | n/a | 3 | Jan 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 57.00 | $50.70 | n/a | 10 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | $2.86 | n/a | 1 | Sep 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €7.50 → €9.00 | $2.29 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €17.00 | $4.47 | n/a | 1 | Jun 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €0.60 → €0.40 | $0.209 | n/a | 4 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €2.70 | $0.384 | n/a | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | $4.14 | n/a | 1 | Dec 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €16.00 | $86.20 | n/a | 1 | Dec 21, 2022 |
GSK plc
May 26, 2026
Upgraded: Buy
Price Target: 1,500p → 2,516p
Current: $1,923.00
Upside: +30.84%
Cosmo N.V.
May 11, 2026
Maintained: Buy
Price Target: CHF 130.00
Current: $66.50
Upside: +95.49%
Sandoz Group AG
May 11, 2026
Maintained: Buy
Price Target: CHF 80.00
Current: $67.68
Upside: +18.20%
Carvolix SA
May 4, 2026
Maintained: Buy
Price Target: €5.00
Current: $3.60
Upside: +38.89%
OSE Immunotherapeutics SA
Apr 30, 2026
Maintained: Buy
Price Target: €8.20
Current: $3.58
Upside: +128.79%
Idorsia Ltd
Apr 28, 2026
Maintained: Buy
Price Target: CHF 4.50
Current: $5.85
Upside: -23.01%
BB Biotech AG
Apr 24, 2026
Maintained: Buy
Price Target: CHF 66.00 → CHF 73.00
Current: $44.20
Upside: +65.16%
Sanofi
Apr 23, 2026
Maintained: Hold
Price Target: €85.00
Current: $73.34
Upside: +15.90%
Formycon AG
Apr 22, 2026
Maintained: Buy
Price Target: €33.00
Current: $19.60
Upside: +68.37%
Novo Nordisk A/S
Apr 20, 2026
Maintained: Hold
Price Target: kr 280.00
Current: $279.92
Upside: +0.03%
Apr 1, 2026
Maintained: Buy
Price Target: €20.30
Current: $15.53
Upside: +30.71%
Mar 6, 2026
Maintained: Buy
Price Target: €36.60
Current: $24.50
Upside: +49.39%
Feb 25, 2026
Maintained: Buy
Price Target: €5.00
Current: $2.90
Upside: +72.41%
Sep 25, 2025
Maintained: Hold
Price Target: €15.00
Current: $9.40
Upside: +59.57%
Jul 17, 2025
Maintained: Hold
Price Target: €390.00
Current: $329.50
Upside: +18.36%
May 6, 2024
Maintained: Sell
Price Target: €0.80 → €0.64
Current: $0.0153
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: $91 → $47
Current: $28.32
Upside: n/a
May 3, 2024
Maintained: Hold
Price Target: €79.00 → €41.00
Current: $24.58
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: $394 → $432
Current: $877.72
Upside: n/a
Feb 20, 2024
Maintained: Hold
Price Target: €342.00 → €375.00
Current: $764.20
Upside: n/a
Jan 10, 2024
Maintained: Buy
Price Target: $14
Current: $1.60
Upside: n/a
Nov 20, 2023
Maintained: Buy
Price Target: CHF 57.00
Current: $50.70
Upside: n/a
Sep 7, 2023
Maintained: Buy
Price Target: €16.00
Current: $2.86
Upside: n/a
Aug 28, 2023
Upgraded: Buy
Price Target: €7.50 → €9.00
Current: $2.29
Upside: n/a
Jun 22, 2023
Maintained: Buy
Price Target: €17.00
Current: $4.47
Upside: n/a
May 3, 2023
Maintained: Buy
Price Target: €0.60 → €0.40
Current: $0.209
Upside: n/a
Apr 28, 2023
Maintained: Buy
Price Target: €2.70
Current: $0.384
Upside: n/a
Dec 29, 2022
Maintained: Buy
Price Target: €12.00
Current: $4.14
Upside: n/a
Dec 21, 2022
Maintained: Buy
Price Target: €16.00
Current: $86.20
Upside: n/a